Paul R. Lockman

9.1k total citations · 3 hit papers
115 papers, 7.0k citations indexed

About

Paul R. Lockman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Paul R. Lockman has authored 115 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 30 papers in Molecular Biology. Recurrent topics in Paul R. Lockman's work include Brain Metastases and Treatment (30 papers), Barrier Structure and Function Studies (18 papers) and Glioma Diagnosis and Treatment (16 papers). Paul R. Lockman is often cited by papers focused on Brain Metastases and Treatment (30 papers), Barrier Structure and Function Studies (18 papers) and Glioma Diagnosis and Treatment (16 papers). Paul R. Lockman collaborates with scholars based in United States, Egypt and Canada. Paul R. Lockman's co-authors include David D. Allen, Joanna Koziara, Russell J. Mumper, David D. Allen, Chris E. Adkins, R. J. Mumper, Rajendar K. Mittapalli, Mansoor A. Khan, Quentin R. Smith and Patricia S. Steeg and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Paul R. Lockman

114 papers receiving 6.9k citations

Hit Papers

Exosome Delivered Anticancer Drugs Across t... 2004 2026 2011 2018 2015 2004 2010 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio
    2015 813 citations Tianzhi Yang, Paige Martin et al. Pharmaceutical Research profile →
  2. Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability
    2004 550 citations Paul R. Lockman, David D. Allen et al. profile →
  3. Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
    2010 524 citations Paul R. Lockman, Rajendar K. Mittapalli et al. Clinical Cancer Research profile →

Peers

Paul R. Lockman
William F. Elmquist United States
Hongzhuan Chen China
David J. Begley United Kingdom
Leslie L. Muldoon United States
Torben Moos Denmark
Ming‐Rong Zhang Japan
Richard Béliveau Canada
Lucienne Juillerat‐Jeanneret Switzerland
Roméo Cecchelli France
José Prados Spain
William F. Elmquist United States
Paul R. Lockman
Citations per year, relative to Paul R. Lockman Paul R. Lockman (= 1×) peers William F. Elmquist

Countries citing papers authored by Paul R. Lockman

Since Specialization
Citations

This map shows the geographic impact of Paul R. Lockman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul R. Lockman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul R. Lockman more than expected).

Fields of papers citing papers by Paul R. Lockman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul R. Lockman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul R. Lockman. The network helps show where Paul R. Lockman may publish in the future.

Co-authorship network of co-authors of Paul R. Lockman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul R. Lockman. A scholar is included among the top collaborators of Paul R. Lockman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul R. Lockman. Paul R. Lockman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arsiwala, Tasneem, et al.. (2025). Single Exposure to Low-Intensity Focused Ultrasound Causes Biphasic Opening of the Blood-Brain Barrier Through Secondary Mechanisms. Pharmaceutics. 17(1). 75–75. 3 indexed citations
2.
Sherman, Jonathan H., et al.. (2024). Targeting drug resistance in glioblastoma (Review). International Journal of Oncology. 65(2). 10 indexed citations
3.
4.
Arsiwala, Tasneem, Samuel A. Sprowls, Peng Wang, et al.. (2023). Blood-tumor barrier opening by MRI-guided transcranial focused ultrasound in a preclinical breast cancer brain metastasis model improves efficacy of combinatorial chemotherapy. Frontiers in Oncology. 13. 1104594–1104594. 9 indexed citations
5.
6.
7.
Mehta, Rashi I., Jeffrey Carpenter, Rupal I. Mehta, et al.. (2021). Blood-Brain Barrier Opening with MRI-guided Focused Ultrasound Elicits Meningeal Venous Permeability in Humans with Early Alzheimer Disease. Radiology. 298(3). 654–662. 74 indexed citations
8.
Lyle, L. Tiffany, Paul R. Lockman, Chris E. Adkins, et al.. (2016). Alterations in Pericyte Subpopulations Are Associated with Elevated Blood–Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Clinical Cancer Research. 22(21). 5287–5299. 120 indexed citations
9.
Mittapalli, Rajendar K., Chris E. Adkins, Kaci A. Bohn, et al.. (2016). Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors. Cancer Research. 77(2). 238–246. 44 indexed citations
10.
Nounou, Mohamed Ismail, Chris E. Adkins, Evelina Rubinchik, et al.. (2016). Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study. Pharmaceutical Research. 33(12). 2930–2942. 33 indexed citations
11.
Yang, Tianzhi, Paige Martin, Alison Brown, et al.. (2015). Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio. Pharmaceutical Research. 32(6). 2003–2014. 813 indexed citations breakdown →
12.
Mittapalli, Rajendar K., Xinli Liu, Chris E. Adkins, et al.. (2013). Paclitaxel–Hyaluronic NanoConjugates Prolong Overall Survival in a Preclinical Brain Metastases of Breast Cancer Model. Molecular Cancer Therapeutics. 12(11). 2389–2399. 76 indexed citations
13.
Fike, David S., et al.. (2011). Improving Community College Student Learning Outcomes in Biology. The Electronic Journal of Science Education. 15(1). 1–12. 4 indexed citations
14.
Taskar, Kunal S., Vinay Rudraraju, Rajendar K. Mittapalli, et al.. (2011). Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer. Pharmaceutical Research. 29(3). 770–781. 160 indexed citations
15.
Lockman, Paul R., Rajendar K. Mittapalli, Kunal S. Taskar, et al.. (2010). Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer. Clinical Cancer Research. 16(23). 5664–5678. 524 indexed citations breakdown →
16.
Dwoskin, Linda P., Thomas E. Wooters, Kiran B. Siripurapu, et al.. (2008). N,N′-Alkane-diyl-bis-3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-Evoked Dopamine Release and Hyperactivity. Journal of Pharmacology and Experimental Therapeutics. 326(2). 563–576. 37 indexed citations
17.
Lockman, Paul R., et al.. (2008). Using WebCt to Implement a Basic Science Competency Education Course. American Journal of Pharmaceutical Education. 72(2). 39–39. 16 indexed citations
18.
Muldoon, Leslie L., Paul G. Tratnyek, Paula Jacobs, et al.. (2006). Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.. PubMed. 27(3). 715–21. 22 indexed citations
19.
Geldenhuys, Werner J., et al.. (2004). Molecular modeling studies on the active binding site of the blood–brain barrier choline transporter. Bioorganic & Medicinal Chemistry Letters. 14(12). 3085–3092. 26 indexed citations
20.
Lockman, Paul R., R. J. Mumper, & David D. Allen. (2003). Evaluation of blood–brain barrier thiamine efflux using the in situ rat brain perfusion method. Journal of Neurochemistry. 86(3). 627–634. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William F. Elmquist Breakdown of academic impact, for papers by Hongzhuan Chen Breakdown of academic impact, for papers by David J. Begley Breakdown of academic impact, for papers by Leslie L. Muldoon Breakdown of academic impact, for papers by Torben Moos Breakdown of academic impact, for papers by Ming‐Rong Zhang Breakdown of academic impact, for papers by Richard Béliveau Breakdown of academic impact, for papers by Lucienne Juillerat‐Jeanneret Breakdown of academic impact, for papers by Roméo Cecchelli Breakdown of academic impact, for papers by José Prados
Rankless by CCL
2026